We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$20M
3
PLTR icon
Palantir
PLTR
+$18.3M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.7M
5
DEO icon
Diageo
DEO
+$16.3M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWU icon
4526
iShares MSCI United Kingdom ETF
EWU
$4.15B
$3.26K ﹤0.01%
82
-457
-85% -$17.6K
CPSH icon
4527
CPS Technologies
CPSH
$83.8M
$3.25K ﹤0.01%
1,174
-2,377
-67% -$5.07K
CIA icon
4528
Citizens
CIA
$194M
$3.25K ﹤0.01%
931
-1,841
-66% -$7.19K
FFTY icon
4529
CapForce IBD 50 ETF
FFTY
$78.9M
$3.25K ﹤0.01%
100
-14,432
-99% -$412K
WLKP icon
4530
Westlake Chemical Partners
WLKP
$764M
$3.25K ﹤0.01%
147
-757
-84% -$17.1K
SGN
4531
DELISTED
Signing Day Sports
SGN
$3.25K ﹤0.01%
3,121
-1,342
-30% -$1.16K
ARMP icon
4532
Armata Pharmaceuticals
ARMP
$169M
$3.24K ﹤0.01%
1,705
-1,766
-51% -$2.86K
FKWL icon
4533
Franklin Wireless
FKWL
$27.9M
$3.24K ﹤0.01%
775
+591
+321% +$2.69K
DMRA
4534
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.82B
$3.21K ﹤0.01%
942
-641
-40% -$1.9K
BEAT icon
4535
Heartbeam
BEAT
$30.5M
$3.2K ﹤0.01%
2,560
+760
+42% +$1.26K
PTIX
4536
DELISTED
Performance Technologies
PTIX
$3.2K ﹤0.01%
876
+453
+107% +$1.74K
SCHR
4537
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$3.18K ﹤0.01%
127
-88,379
-100% -$2.19M
SUPV
4538
Grupo Supervielle
SUPV
$742M
$3.18K ﹤0.01%
300
-13
-4% -$176
INAB icon
4539
IN8bio
INAB
$9.61M
$3.17K ﹤0.01%
1,517
+841
+124% +$3.42K
SDEV
4540
Stablecoin Development Corp
SDEV
$51.5M
$3.16K ﹤0.01%
1,090
-1
-0.1% -$3
TUR icon
4541
iShares MSCI Turkey ETF
TUR
$217M
$3.16K ﹤0.01%
+98
New +$3.08K
WVVI icon
4542
Willamette Valley Vineyards
WVVI
$11.7M
$3.16K ﹤0.01%
569
+49
+9% +$286
GIB icon
4543
CGI
GIB
$15.6B
$3.15K ﹤0.01%
30
-6,167
-100% -$650K
RDY icon
4544
Dr. Reddy's Laboratories
RDY
$10.1B
$3.14K ﹤0.01%
+209
New +$2.98K
RNAZ icon
4545
TransCode Therapeutics
RNAZ
$4.11M
$3.14K ﹤0.01%
402
+347
+631% +$3.21K
IMNN icon
4546
Imunon
IMNN
$6.85M
$3.13K ﹤0.01%
300
-13
-4% -$178
GORO icon
4547
Goldgroup Mining Inc.
GORO
$186M
$3.13K ﹤0.01%
5,130
-12,154
-70% -$6.61K
DRMA icon
4548
Dermata Therapeutics
DRMA
$4.5M
$3.11K ﹤0.01%
532
+352
+196% +$2.7K
PALI icon
4549
Palisade Bio
PALI
$365M
$3.11K ﹤0.01%
4,567
-3
-0.1% -$2
ALLR
4550
Allarity Therapeutics
ALLR
$22.4M
$3.1K ﹤0.01%
3,073
-1,632
-35% -$1.54K
180 181
182
183 184

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.